Chemotherapy | Blood Cancers Today

Chemotherapy

Leah SherwoodAggressive B-Cell Lymphoma | March 23, 2023

Pola-R-CHP may be cost-effective for the treatment of DLBCL.

Leah SherwoodAcute Lymphoblastic Leukemia | November 22, 2022

A new study found that more than one-third of patients aged older than 65 years do not receive...

Leah SherwoodAggressive B-Cell Lymphoma | November 14, 2022

The phase III GALLIUM study confirmed obinutuzumab plus chemotherapy as a standard of care for first-line follicular lymphoma

Sabrina AhleMantle Cell Lymphoma | February 2, 2023

Researchers have discovered that chemotherapy and COVID-19 infection cause neuro-inflammation in similar ways.

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer